Casdin Capital Portfolio

Casdin Capital 13F filer (CIK 0001534261).

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth TiltHigh Turnover how tags are computed

Q3 2018 · 36 positions · Total reported value $822.76M · Top-10 concentration 55.9% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 26.1% · 6 new · 3 cut · 3 exited

Active Share (vs S&P 500): 99.8% · vs QQQ: 99.9% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +47.2% · vs SPY +32.4% · Prev Value $1.32B — last quarter positions weighted by this quarter price moves · ranking

In its Q3 2018 13F filing, Casdin Capital disclosed 36 equity positions with a combined reported value of $822.76M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 55.9% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2018 were LOXO ($61.50M), BPMC ($58.55M), MYOK ($52.49M). By sector, the heaviest allocations are Health Care 35.7%, Industrials 4.2%. Versus the prior quarter, allocation shifted toward Other (+1.2pp) and away from Industrials (-0.7pp).

Versus the prior quarter, Casdin Capital opened 6 new positions, trimmed 3 and fully exited 3, a turnover rate of 26.1% of positions. The portfolio's overlap with the prior quarter was 79% of names.

The largest new positions opened in Q3 2018 were NVTAQ ($40.15M), GRTSQ ($10.26M), CNST ($8.85M).

Of the 3 positions fully exited versus the prior quarter, the largest were FMI ($93.64M), ZLAB ($3.14M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2018)

  • NVTAQ INVITAE CORP · $40.15M
  • GRTSQ GRITSTONE BIO INC · $10.26M
  • CNST CONSTELLATION PHARMCETICLS I · $8.85M
  • SRPT SAREPTA THERAPEUTICS INC · $6.46M
  • CELG CELGENE CORP · $4.47M
  • GILD GILEAD SCIENCES INC · $3.86M

Fully Exited (vs previous quarter)

  • FMI FOUNDATION MEDICINE INC · prev qtr: $93.64M
  • ZLAB Zai Lab Ltd · prev qtr: $3.14M

Insider Transactions (Form 4)

Latest Casdin Capital buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Casdin Capital is an SEC-registered 13F filer based in New York, NY, United States. As of Q2 2026 it reported 43 US equity positions with a combined value of $2.00B. HoldingsHub carries 43 quarters of its filings (Q4 2015–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-110894 (status: Approved), registered 2017-07-31
  • Regulatory AUM (Form ADV): $2.87B as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 5 private funds, of which 2 hedge funds

Portfolio Structure

  • 43 positions · $2.00B reported value (Q2 2026)
  • Top 10 holdings = 77.4% of reported value
  • Largest position: RVMD (REVOLUTION MEDICINES INC) at 24.2%
  • Average position size: $46.46M

Sector Tilt

  • Health Care 94.2%
  • Industrials 5.7%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 6 new, 9 added, 3 reduced, 3 exited
  • 25 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 35.7%
Other 58.1%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 360.00K $61.50M 7.47%
7.47%
Add
2 750.00K $58.55M 7.12%
7.12%
Add
3 805.00K $52.49M 6.38%
6.38%
Add
4 579.78K $44.71M 5.43%
5.43%
Add
5 312.00K $44.07M 5.36%
5.36%
Add
6 2.43M $42.50M 5.17%
5.17%
Add
7 2.55M $41.54M 5.05%
5.05%
Reduce
8 2.40M $40.15M 4.88%
4.88%
New
9 258.00K $37.67M 4.58%
4.58%
Add
10 675.00K $36.82M 4.47%
4.47%
Add
11 2.02M $34.73M 4.22%
4.22%
Hold
12 2.00M $33.90M 4.12%
4.12%
Add
13 2.25M $27.03M 3.29%
3.29%
Add
14 71.50K $26.25M 3.19%
3.19%
Hold
15 3.50M $25.73M 3.13%
3.13%
Add
16 625.00K $24.74M 3.01%
3.01%
Add
17 270.00K $23.63M 2.87%
2.87%
Hold
18 1.14M $21.47M 2.61%
2.61%
Hold
19 440.00K $16.72M 2.03%
2.03%
Add
20 550.00K $15.62M 1.90%
1.90%
Hold
21 460.00K $14.64M 1.78%
1.78%
Add
22 70.00K $12.05M 1.47%
1.47%
Hold
23 720.59K $10.26M 1.25%
1.25%
New
24 220.00K $9.76M 1.19%
1.19%
Hold
25 1.31M $8.85M 1.07%
1.07%
New
26 525.00K $8.11M 0.99%
0.99%
Reduce
27 350.00K $8.00M 0.97%
0.97%
Add
28 235.00K $6.90M 0.84%
0.84%
Add
29 40.00K $6.46M 0.79%
0.79%
New
30 200.00K $5.77M 0.70%
0.70%
Hold
31 65.00K $4.65M 0.56%
0.56%
Hold
32 50.00K $4.47M 0.54%
0.54%
New
33 50.00K $3.86M 0.47%
0.47%
New
34 207.50K $3.84M 0.47%
0.47%
Hold
35 338.35K $2.89M 0.35%
0.35%
Hold
36 375.00K $2.44M 0.30%
0.30%
Hold

FAQ

What did Casdin Capital buy in 2018-Q3?

In its 2018-Q3 13F filing, Casdin Capital reported 36 equity positions worth $822.76M in aggregate; its largest disclosed positions were LOXO ($61.50M), BPMC ($58.55M), MYOK ($52.49M).

How large is Casdin Capital's portfolio?

Casdin Capital reported $822.76M of long equity holdings across 36 positions as of 2018-Q3. Top-10 holdings account for 55.9% of reported value.

What is Casdin Capital's investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/casdin/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →